Australian Leukemia News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Press Release Stockholm, Sweden, March 12, 2024 ADVANCE II Phase 2 trial data provide basis for late-stage development of lead product vididencel in acute myeloid leukemiaRegistration trial.

United statesErik mantingLymphoma groupAmerican society for hematologyNorthx biologicsBusiness updateAmerican societyAustralian leukemiaInderes event studioNasdaq stockholm